These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9049578)

  • 41. Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension.
    Predel HG; Mainka W; Schillings W; Knigge H; Montiel J; Fallois J; Agrawal R; Schramm T; Graf C; Giannetti BM; Bjarnason-Wehrens B; Prinz U; Rost RE
    J Hum Hypertens; 2001 Oct; 15(10):715-21. PubMed ID: 11607802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemodynamic effects and pharmacokinetics of oral d- and l-nebivolol in hypertensive patients.
    Himmelmann A; Hedner T; Snoeck E; Lundgren B; Hedner J
    Eur J Clin Pharmacol; 1996; 51(3-4):259-64. PubMed ID: 9010695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients.
    Zanchetti A
    Blood Press Suppl; 2004 Oct; 1():17-32. PubMed ID: 15587108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics.
    Agabiti Rosei E; Rizzoni D
    Drugs; 2007; 67(8):1097-107. PubMed ID: 17521213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic beta-blockade does not influence muscle power output during high-intensity exercise of short-duration.
    Derman WE; Dunbar F; Haus M; Lambert M; Noakes TD
    Eur J Appl Physiol Occup Physiol; 1993; 67(5):415-9. PubMed ID: 7905412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nebivolol and airway responsiveness in the rabbit.
    D'Agostino B; Gallelli L; Falciani M; Fici F; Mangrella M; Rossi F; Filippelli A
    Life Sci; 2001 Mar; 68(18):2159-68. PubMed ID: 11324721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
    Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes.
    Fogari R; Zoppi A; Lazzari P; Mugellini A; Lusardi P; Preti P; Van Nueten L; Vertommen C
    J Hum Hypertens; 1997 Nov; 11(11):753-7. PubMed ID: 9416986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation.
    Weiss R
    Vasc Health Risk Manag; 2006; 2(3):303-8. PubMed ID: 17326335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nebivolol prevents desensitization of β-adrenoceptor signaling and induction of cardiac hypertrophy in response to isoprenaline beyond β1-adrenoceptor blockage.
    Ozakca I; Arioglu-Inan E; Esfahani H; Altan VM; Balligand JL; Kayki-Mutlu G; Ozcelikay AT
    Am J Physiol Heart Circ Physiol; 2013 May; 304(9):H1267-76. PubMed ID: 23457011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of beta-adrenoceptor antagonists on cardiac function in ischemic-reperfused myocardium of the isolated working rabbit heart.
    Lu HR; Vandeplassche G; Wouters L; Flameng W; Borgers M
    Eur J Pharmacol; 1990 Aug; 184(1):65-74. PubMed ID: 1976531
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
    Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L
    Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nebivolol dilates human penile arteries and reverses erectile dysfunction in diabetic rats through enhancement of nitric oxide signaling.
    Angulo J; Wright HM; Cuevas P; González-Corrochano R; Fernández A; Cuevas B; La Fuente JM; Gupta S; Sáenz de Tejada I
    J Sex Med; 2010 Aug; 7(8):2681-97. PubMed ID: 20214719
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol.
    Lipworth BJ; Irvine NA; McDevitt DG
    Eur J Clin Pharmacol; 1991; 40(2):135-9. PubMed ID: 1676675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients.
    Poirier L; Cléroux J; Nadeau A; Lacourcière Y
    J Hypertens; 2001 Aug; 19(8):1429-35. PubMed ID: 11518851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol.
    Nodari S; Metra M; Dei Cas L
    Eur J Heart Fail; 2003 Oct; 5(5):621-7. PubMed ID: 14607201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term treatment with nebivolol attenuates renal damage in Zucker diabetic fatty rats.
    Toblli JE; Cao G; Giani JF; Muñoz MC; Angerosa M; Dominici FP
    J Hypertens; 2011 Aug; 29(8):1613-23. PubMed ID: 21720265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of nebivolol stereoisomers on the action of adrenaline on blood pressure, heart rate and blood levels of noradrenaline and DOPEG.
    Borges N; Martel F; Branco D; Osswald W
    J Auton Pharmacol; 1992 Dec; 12(6):429-35. PubMed ID: 1361931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparison of effects of nebivolol and atenolol on P-wave dispersion in patients with hypertension].
    Tuncer M; Fettser DV; Gunes Y; Batyraliev TA; Guntekin U; Gumrukchuoglu KhA; Eryonucu B; Guler N; Sidorenko BA
    Kardiologiia; 2008; 48(4):42-5. PubMed ID: 18447840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.